Skip to main content

Department

Toxicology

Preferred Sample Type

Verapamil

Suitable Specimen Types

  • Serum
  • EDTA Plasma
  • Li Hep Plasma
A minimum of 500 µl of plasma/serum is required.

Specimen Transport

First class post

Sample Processing in Laboratory

Place sample in toxicology rack.

Sample Preparation

None required

Turnaround Time

3 days.

Sample Stability

Keep refrigerated. 4 degrees.

Verapamil

General Information

Verapamil is a synthetic papaverine derivative, first introduced in 1962 as an anti-anginal agent. It has since been found to have anti-arrhythmic and anti-hypertensive properties, attributable to its ability to inhibit transmembrane calcium flux in excitable tissues. Daily adult oral maintenance doses range from 240 – 480 mg, while single i.v doses of 5 – 10 mg are used for hypertensive crises.

Adverse effects associated with verapamil administration include nausea, weakness, dizziness, bradycardia, hypotension and atrioventricular block. Intravenous calcium gluconate may be able to reverse cardiac toxicity observed. 

Patient Preparation

For TDM, sample should be taken prior to dose. If toxicity is suspected, take sample at earliest opportunity

Notes

Verapamil measured by HPLC-DAD.

Reference Range

Therapeutic use of verapamil is associated with blood concentrations of up to 0.4 mg/L. Toxicity is associated with verapamil levels > 1 mg/L. (Schulz et al. Critical Care 2012, 16:R136).

Specifications

  • EQA Scheme?: Yes
  • EQA Status: LGC QUARTZ, LGC CLIN TOX